Suppr超能文献

经皮介入治疗锁骨下动脉至对侧锁骨下静脉“项链式”血液透析移植物:5例患者的经验

Percutaneous interventions in subclavian artery-to-contralateral subclavian vein "necklace" hemodialysis grafts: experience in five patients.

作者信息

Fidelman Nicholas, Allen Derrick, Bloom Allan I, LaBerge Jeanne M, Hastings Geoffrey S, Kerlan Robert K, Gordon Roy L, Wilson Mark W

机构信息

Department of Radiology, University of California, San Francisco, 505 Parnassus Ave, Rm M-361, San Francisco, CA 94143, USA.

出版信息

J Vasc Interv Radiol. 2007 May;18(5):597-601. doi: 10.1016/j.jvir.2007.02.017.

Abstract

PURPOSE

To describe clinical outcomes of endovascular interventions in the setting of thrombosis or dysfunction of anterior chest wall ("necklace") arteriovenous (AV) hemodialysis grafts.

MATERIALS AND METHODS

Eight percutaneous interventions (balloon angioplasty, pharmacologic thrombolysis, and mechanical thrombectomy) were performed in five patients with anterior chest wall AV grafts. Primary, assisted, and secondary patencies, as well as technical success and complication rates, were determined.

RESULTS

The technical success rate of percutaneous interventions in re-establishing a normal blood flow pattern within the AV grafts was 100%. Primary patency ranged from one to 23 months (median, 5 months). Primary assisted patency and secondary patency were 36 months and 8 months, respectively, in two patients who underwent more than one intervention. Postintervention access patency ranged from 5 to 36 months (median, 9 months), whereas graft lifetime ranged from 12 to 45 months (median, 24 months). There were no complications related to revascularization procedures.

CONCLUSION

Percutaneous interventions can be performed safely and effectively in anterior chest wall AV grafts. Technical success and long-term patency rates appear to be similar to those of percutaneous interventions in upper-extremity hemodialysis AV grafts.

摘要

目的

描述在前胸壁(“项链”)动静脉(AV)血液透析移植物发生血栓形成或功能障碍的情况下,血管内介入治疗的临床结果。

材料与方法

对5例前胸壁AV移植物患者进行了8次经皮介入治疗(球囊血管成形术、药物溶栓和机械血栓切除术)。确定了初次通畅率、辅助通畅率和二次通畅率,以及技术成功率和并发症发生率。

结果

经皮介入治疗在重建AV移植物内正常血流模式方面的技术成功率为100%。初次通畅时间为1至23个月(中位数为5个月)。在接受不止一次介入治疗的2例患者中,初次辅助通畅时间和二次通畅时间分别为36个月和8个月。介入治疗后通路通畅时间为5至36个月(中位数为9个月),而移植物使用寿命为12至45个月(中位数为24个月)。没有与血运重建手术相关的并发症。

结论

经皮介入治疗在前胸壁AV移植物中可以安全有效地进行。技术成功率和长期通畅率似乎与上肢血液透析AV移植物的经皮介入治疗相似。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验